NasdaqGM - Nasdaq Real Time Price USD
Aquestive Therapeutics, Inc. (AQST)
As of 11:12 AM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 35,000 | 2 |
| Sales | 25,000 | 1 |
| Net Shares Purchased (Sold) | 10,000 | 3 |
| Total Insider Shares Held | 4.57M | -- |
| % Net Shares Purchased (Sold) | 0.20% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| KORCZYNSKI SHERRY Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 7, 2024 |
| WARGACKI STEPHEN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 10, 2024 |
| SCHOBEL ALEXANDER MARK Officer | Sale at price 6.00 per share. | Direct | 300,000 | Mar 15, 2024 |
| SCHOBEL ALEXANDER MARK Chief Technology Officer | Sale at price 5.19 per share. | Direct | 129,685 | Mar 8, 2024 |
| SCHOBEL ALEXANDER MARK Officer | Sale at price 5.19 per share. | Direct | 129,685 | Mar 8, 2024 |
| TOTH A ERNEST JR Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 7, 2024 |
| SCHOBEL ALEXANDER MARK Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 7, 2024 |
| BARBER DANIEL Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 7, 2024 |
| BOYD PETER E Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 7, 2024 |
| BRAENDER LORI J General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 7, 2024 |
| KRAUS CARL N Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 7, 2024 |
| JUNG CASSIE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 7, 2024 |
| WARGACKI STEPHEN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 7, 2024 |
| KRAUS CARL N Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 9, 2023 |
| TOTH A ERNEST JR Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 9, 2023 |
| MARSHALL KEN W Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 9, 2023 |
| SCHOBEL ALEXANDER MARK Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 9, 2023 |
| BARBER DANIEL Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 9, 2023 |
| BOYD PETER E Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 9, 2023 |
| BRAENDER LORI J General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 9, 2023 |
| JUNG CASSIE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 9, 2023 |
| WARGACKI STEPHEN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 9, 2023 |
Related Tickers
ETON Eton Pharmaceuticals, Inc.
8.41
-0.36%
AKBA Akebia Therapeutics, Inc.
1.5199
+10.98%
ESPR Esperion Therapeutics, Inc.
2.0588
-0.06%
ITCI Intra-Cellular Therapies, Inc.
77.72
+1.05%
DVAX Dynavax Technologies Corporation
11.00
+0.14%
AVDL Avadel Pharmaceuticals plc
13.50
+0.60%
TLPH Talphera, Inc.
1.0110
-0.88%
IRWD Ironwood Pharmaceuticals, Inc.
4.1000
-2.15%
AMRX Amneal Pharmaceuticals, Inc.
8.49
+0.18%
ANIP ANI Pharmaceuticals, Inc.
59.19
-0.16%